Skip to main content
Clinical Trials/NCT02636894
NCT02636894CompletedNot Applicable

Evaluation of the Efficacy of Restylane Silk in the Treatment of Cheek Fold (Radial Smile Lines)

Amanda D. Spear, CCRC0 sites30 target enrollmentStarted: March 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
30
Primary Endpoint
Evaluation of the Efficacy of Restylane Silk in the Treatment of Cheek folds (Radial Smile Lines)

Study Overview

Brief Summary

Filler study for smile lines in cheek folds

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Male or female between 21-65 years of age
  • •Willing to comply with study visits and procedures
  • •Willingness to refrain form surgical, laser, or injectable treatments in cheek region during study

Exclusion Criteria

  • •History of trauma, acne scarring, burns, or other changes to skin in treatment area
  • •Use of botulinum toxin in the lateral cheeks/perioral region in past 6 months
  • •Use of injectable fillers in the lateral cheeks/perioral within last 2 years
  • •History of facelift in the last year
  • •History of facial nerve palsy

Arms & Interventions

Restylane Silk

Other

Restylane Silk

Intervention: Restylane Silk (Device)

Outcomes

Primary Outcomes

Evaluation of the Efficacy of Restylane Silk in the Treatment of Cheek folds (Radial Smile Lines)

Time Frame: 6 months

Improvement of subjects based on 5 point global aesthetic scale (GAIS)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Amanda D. Spear, CCRC
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Amanda D. Spear, CCRC

Brian Biesman, MD

Nashville Centre for Laser and Facial Surgery

Similar Trials